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Cardiomyocytes from human stem cells have applications in regenerative medicine and can provide
models for heart disease and toxicity screening. Soluble components of the culture system such as
growth factors within serum and insoluble components such as the substrate on which cells adhere to
are important variables controlling the biological activity of cells. Using a combinatorial materials
approach we develop a synthetic, chemically deﬁned cellular niche for the support of functional car-
diomyocytes derived from human embryonic stem cells (hESC-CMs) in a serum-free fully deﬁned culture
system. Almost 700 polymers were synthesized and evaluated for their utility as growth substrates. From
this group, 20 polymers were identiﬁed that supported cardiomyocyte adhesion and spreading. The most
promising 3 polymers were scaled up for extended culture of hESC-CMs for 15 days and were charac-
terized using patch clamp electrophysiology and myoﬁbril analysis to ﬁnd that functional and structural
phenotype was maintained on these synthetic substrates without the need for coating with extracellular
matrix protein. In addition, we found that hESC-CMs cultured on a co-polymer of isobornyl methacrylate
and tert-butylamino-ethyl methacrylate exhibited signiﬁcantly longer sarcomeres relative to gelatin
control. The potential utility of increased structural integrity was demonstrated in an in vitro toxicity
assay that found an increase in detection sensitivity of myoﬁbril disruption by the anti-cancer drug
doxorubicin at a concentration of 0.05 mM in cardiomyocytes cultured on the co-polymer compared to
0.5 mM on gelatin. The chemical moieties identiﬁed in this large-scale screen provide chemically deﬁned
conditions for the culture and manipulation of hESC-CMs, as well as a framework for the rational design
of superior biomaterials.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The differentiation of hESCs to cardiomyocytes was ﬁrst re-
ported in 2000 [1] and has since undergone improvements inac.uk (M.R. Alexander), chris.
Ltd. This is an open access articleculture conditions to include staged addition of growth factors to
increase differentiation efﬁciency [2], replacement of these factors
with small molecules to reduce cost [3] and deﬁned medium
components to improve reproducibility [4]. However, progress in
the development of deﬁned and reproducible synthetic substrates
has been limited by a lack of understanding of the cellesurface
interactions that control cell phenotype. Pre-adsorption of extra-
cellular matrix (ECM) proteins such as gelatin, laminin and ﬁbro-
nectin offer varying degrees of support for cardiomyocyte adhesion
[5]. However, common synthetic substrates, such as tissue cultureunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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shown to cause catastrophic loss of sarcomeric integrity [6]. Bio-
logical substrates can be expensive, have a limited shelf life and are
subject to batch variation. Such matrices are often assumed to be
inert and their effect on cell behavior is over-looked [7]. In addition,
undeﬁned fetal bovine serum (FBS) commonly added to culture
medium has been shown to alter phenotype thereby masking drug
and disease effects [8]. Synthetic culture substrates, together with
deﬁned serum-free media components, could circumvent these
concerns [9]. A wide chemical survey of the underlying substrate
supporting the cells has not previously been investigated for their
effect on hESC-CM adhesion and function.
High throughput screening (HTS) strategies for biomaterials
development have proved successful in identifying substrates
capable of supporting clinically relevant cell types including hESCs
[10e13], pancreatic islet cells [14] and hepatocytes [15]. The current
study has employed a parallel screening approach to investigate the
inﬂuence of a range of (meth)acrylate and (meth)acrylamide
polymers on hESC-CM adhesion and functionality. Members of this
class of polymers were selected due to the large chemical diversity
available commercially and because they are amenable to in situ
free-radical polymerization. Over 1700 substrates can be presented
in a single polymer microarray by depositing nano-liter volumes of
monomer into discrete 300 mm islands by piezo or contact printing
and polymerizing on-slide [16]. Coupled with high throughput
surface characterization [17], high content imaging systems and
automated image analysis [18], we present a powerful strategy to
rapidly identify materials that support functional hESC-CMs in fully
deﬁned conditions and demonstrate potential applications for such
a system in drug toxicity screening.2. Materials and methods
2.1. Cell culture
EB differentiation: Cardiac differentiation was adapted from
previously published protocols [19,20]. Brieﬂy, embryoid body (EB)
formation of the HUES7 [21] cell line was initiated in untreated
polystyrene 96 V-well plates (NUNC, 249662) by seeding each well
with 4000 cells in 100 mL of RPMI 1640 medium (Invitrogen) sup-
plemented with 1 insulin transferrin selenium (Invitrogen), 1
chemically deﬁned lipid (Invitrogen), 400 mM 1-thioglycerol
(Sigma) (denoted RILT medium) plus 0.4% Poly(vinyl alcohol)
(Sigma) and growth factors 20 ng/mL BMP-4 (R&D) and 6 ng/mL
basic FGF (Peprotech) to direct differentiation to cardiomyocytes.
Plates were incubated for 48 h at 37 C, 5% CO2 and medium
changed to RPMI 1640 supplemented with 20% FBS and incubated
for a further 48 h. At day 4 of differentiation, EBs were transferred
to a tissue culture polystyrene 96U-well plate (NUNC, 168136) in
150 mL of RILT mediumwhich was changed every 3 days. EBs began
to spontaneously beat from day 8.
Monolayer differentiation: A previously published protocol [4]
was followed. Brieﬂy, HUES7 cells were seeded at a density of
1.2  104 cells per cm2 in a tissue culture polystyrene T ﬂask coated
with Matrigel (BD Biosciences). Differentiationwas initiated on day
4 using 6 mM of CHIR99021 (Tocris) in chemically deﬁned medium
(CDM)which comprises of RPMI 1640, 213 mg/mL of L-ascorbic acid-
2-phosphate (SigmaeAldrich) and 500 mg/mL of human recombi-
nant albumin (SigmaeAldrich). After 48 h, mediumwas changed to
CDM containing 2 mM Wnt-C59 (Tocris). After a further 48 h,
mediumwas changed to CDM andmaintained in this medium for 2
days and then switched to RILT medium for maintenance. Spon-
taneous beating was observed between day 7 and 9 from initiation
of differentiation.2.2. Cardiomyocyte cluster disaggregation
Beating clusters of cells within EBs were dissected at day 15 of
differentiation, washed in PBS and transferred to a mixture of 0.05%
trypsin-EDTA and AccuMax (Innovative CellTech) in a 3:1 ratio and
incubated for 8 min (with vortexing at 4 min intervals). Dissocia-
tion was conﬁrmed with gentle pipetting. Partially dissociated
clusters were transferred to fresh enzyme mix to repeat the incu-
bation and vortex process. Meanwhile, the remaining enzyme-cell
suspension was quenched with an equal volume of RPMI supple-
mented with 20% FBS and centrifuged for 3 min at 300G. The su-
pernatant was gently aspirated and the cell pellet re-suspended in a
small volume of RILT medium until all clusters were disaggregated
and pooled together. Monolayer cultures were disaggregated using
the same enzyme mixture with exposure reduced to 3 min in total
followed by quenching and centrifugation steps as described above.
2.3. Polymer microarray synthesis
Polymer microarrays were fabricated as described previously
[22]. Brieﬂy, monomer solutions (Sigma Aldrich, Scientiﬁc Poly-
mers and Polyscience) were spotted, using a XYZ3200 dispensing
station (Biodot) and metal pins (946MP3B, Arrayit), onto epoxy-
glass slides (Genetix) dip-coated with pHEMA (4% w/v, Sigma) in
ethanol (95% v/v in water). The printing conditions were
O2 < 2000 ppm, 25 C, and 35% humidity. Homopolymer solutions
were composed of monomer (50% v/v) in dimethylformamide with
photo-initiator 2,2-dimethoxy-2-phenyl acetophenone (1% w/v).
Six replicates of 116 homopolymers were printed on each slide of a
ﬁrst generation array. The monomer portion of co-polymer solu-
tions consisted of major monomer andminormonomer in a 30/70%
v/v ratio. Three replicates of 576 co-polymers were printed in
second generation arrays. Co-polymers were scaled up by piezo
printing using a SciﬂexarrayerS11 (Scienion) onto 35 mm dishes
(NUNC, 150318) that had been oxygen plasma etched at 30 W for
10 min (BioRad, PT7100) and coated with 4% pHEMA solution. Prior
to seeding with cells, all substrates were UV sterilized, washedwith
phosphate buffered saline (PBS, Invitrogen) and incubated for 1 h
with either RILT medium alone or supplemented with 20% Fetal
Bovine Serum (FBS) (Invitrogen). The seeding density of car-
diomyocytes was optimized at 80,000 cells per microarray to avoid
high densities leading to very high cell counts which would lead to
inaccurate automated image analysis (Fig. S1).
2.4. Whole cell patch clamp electrophysiology
Recordings were performed in current clamp mode using an
ECP-10 HEKA ampliﬁer. Cells were maintained in Normal Tyrodes
buffer (140 mM NaCl, 10 mM glucose, 10 mM HEPES, 4 mM KCl,
1 mM MgCl2, 1.8 mM CaCl2, pH 7.45/NaOH) and at near-
physiological temperatures (37 ± 2 C). Patch pipettes were
pulled on a Sutter P-97 programmable micropipette puller and had
resistances of between 2 and 5 MU when ﬁlled with the internal
solution (145 mM KCl, 5 mM NaCl, 2 mM CaCl2, 2 mMMgCl2, 4 mM
EGTA, 10 mM HEPES, pH 7.3/KOH). Pulse (HEKA) and Clampﬁt v9.0
(Molecular Devices) software were used for data acquisition and
analysis respectively. To determine the sub-type of the car-
diomyocyte, APD90/50 ratios were calculated and designated as
ventricular <1.4, nodal 1.4e1.7 and atrial >1.7. Ventricular sub-
types were selected for further action potential proﬁling.
2.5. Immunostaining
Cells were ﬁxed in 4% paraformaldehyde (Sigma) and per-
meabilized with 0.1% Triton-X 100 (Sigma). Non-speciﬁc binding
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were immunostained with primary antibody against human car-
diac sarcomeric a actinin raised inmouse (1:800; Sigma). After 24 h
and a 0.1% Tween20 (Sigma) wash, samples were exposed to Cy3-
conjugated goat anti-mouse secondary antibody IgG þ IgM
(1:250; Jackson Immuno Research) and 40,6-diamidino-2-
phenylindole (DAPI) (1:1000; Sigma). Samples were mounted in
VectorShield mounting medium (Vector Labs, Peterborough, UK)
and imaged using an automated ﬂuorescence microscope
(IMSTAR).
2.6. Doxorubicin assay
hESC-CMs differentiated using the monolayer method were
seeded onto the selected co-polymers or 0.1% gelatin coated dishes
in RILT medium and incubated for 15 days with medium changes
every 3 days. Doxorubicin (Cell Signaling) was diluted in dimethyl
sulfoxide (DMSO, Hybri-Max, Sigma) to a stock concentration of
5 mM. This was diluted further in RILT medium to 0.05 mM, 0.5 mM
and 5 mM concentrations. The ﬁnal concentration of DMSO in each
dilutionwas kept constant. Cells were treated with the doxorubicin
spiked RILT medium at day 15 of culture and cells were incubated
for 24 h before ﬁxing for immunostaining. Disrupted myoﬁbrils
were considered to be sarcomere lengths of less than 1.4 mm [23] or
punctate staining where no myoﬁbril banding could be observed.
2.7. Image analysis
Automated image analysis of cardiomyocyte density, cell area
and shape was achieved by building a custom protocol using Cell-
Proﬁler open source software [18]. CellProﬁler pipelines can be
found at www.CellProﬁler.org. The lengths of sarcomeres within
myoﬁbrils were measured using the line proﬁle tool in Image J
downloaded from http://imagej.nih.gov/ij/. Cells within images
were randomly selected by ‘object number’ using x, y co-ordinates
generated by CellProﬁler software during individual cell analysis
(Fig. S2.).
2.8. Time-of-ﬂight secondary-ion mass spectrometry
ToF-SIMS analysis was carried out using a ToF-SIMS IV instru-
ment (ION-TOF GmbH, Münster, Germany) using a Bi3þ primary ion
source operated at 25 kV. A 1 pA pulsed primary ion beam was
rastered and secondary ions were collected from a 10 10mm area
at a resolution of 100 pixels per mm, with 8 ion pulses per pixel. An
ion dose of 2.45  1011 ions per cm2 was applied to each sample
area ensuring static conditions. To compensate for a surface build
up of positive primary ions, low energy electrons (20 eV) were
delivered via a ﬂood gun. Data analysis was carried out using Sur-
facelab6 software.
2.9. Partial least squares (PLS) multivariate linear regression
To correlate surface analytical data with cell response PLS was
carried out using the Eigenvector PLS toolbox 5.2.2 for Matlab using
the SIMPLS algorithm [24]. A peak list was generated for the ho-
mopolymer array consisting of 1397 ions. Mean-centered data pre-
processing was applied and a leave-one-out cross validation was
carried out to obtain errors for latent variables. The model was
generated using 80% of the data (training set) and validated by
predicting values for the remaining 20% of the data [25]. These
models provide a means of study for systems where there is limited
a priori knowledge and also removes subjective manual analysis of
variables to create statistically valid models [26].3. Results
3.1. Commercially available (meth)acrylate and (meth)acrylamide
homopolymers are unable to support hESC-CM adhesion in serum-
free conditions
To investigate whether surface chemistry can inﬂuence car-
diomyocyte adhesion and spreading, a library of 96 (meth)acrylate
and 20 (meth)acrylamide monomers with various side chain
chemistries (Table S1) were arrayed onto glass slides coated with
poly(2-hydroxyethyl methacrylate) (pHEMA) to anchor spots and
reduce background cell adhesion (Fig. 1). Beating clusters of hESC-
CMswere dispersed and seeded onto arrays (Fig.1A) that had either
been pre-conditioned with deﬁned serum-free medium ormedium
supplemented with 20% fetal bovine serum (FBS) for 1 h. Cultures
were maintained for 7 days on microarrays in serum-free medium
before processing for immunostaining against the cardiac speciﬁc
structural protein, a actinin, that resides in the Z bands of the
myoﬁbril and its staining pattern provides information on cell
structure, size and maturity (Fig. 1C). Seeding densities were opti-
mized to allow accurate automated image analysis using CellPro-
ﬁler. Very high densities were found to lead to inaccurate counts
and low densities failed to reveal differences in levels of cell
adhesion on various polymers (Fig. S1). It was found that on arrays
pre-conditioned with FBS, 48 of the 116 homopolymers supported
hESC-CM adhesion (Fig. S3A). However, in the absence of serum,
only 7 supported adhesion to a level comparable with the gelatin
control (Fig. S3B), underlining the dependency on FBS for adhesion.
The highest number of attached cells in serum-free conditions was
on two structurally related amine-containing polyacrylates; tert-
butylamino-ethyl methacrylate (monomer 17) and dimethylamino-
propyl acrylate (monomer 6) (Fig. 1D). However, average cell size
was low (274 mm2 and 110 mm2 respectively) compared to car-
diomyocytes on gelatin control (1560 mm2). Cardiomyocytes with
an average cell size greater than 500 mm2 is desired as they
represent more mature, later stage cardiomyocytes that are more
likely to contain well-organized structural protein for functional
cell contraction [27]. Poly(2-(methacryloyloxy)ethyl acetoacetate)
(monomer 20) supported the largest average cell size (769 mm2) in
serum-free conditions but had low cell attachment numbers. On
serum pre-conditioned arrays, where we assume the surface is
dominated by the adsorbed proteins [28], there was a diverse range
of adhesion and spreading which is consistent with the observation
that surface chemistry can alter protein adsorption and/or confor-
mation that subsequently inﬂuences cell adhesion [29,30]. For
example, when cultured with serum proteins, poly(furfuryl meth-
acrylate) (monomer 14) is capable of supporting greater cell adhe-
sion compared to poly(2-(methacryloyloxy)ethyl acetoacetate)
(monomer 20) (Fig. 1D). However, in serum-free conditions, both
polymers supported similarly low densities of cardiomyocytes. This
initial screen identiﬁed polymers that demonstrated either high
cell attachment or larger cell size but not both, consequently we
sought to investigate if co-polymerization could capture both
desired traits.
3.2. Combinatorial development of co-polymers enables improved
cardiomyocyte adhesion and cell spreading in serum-free conditions
To investigate if attachment and cell spreading in serum-free
conditions could be improved, we selected 24 polymers from
both serum-free and serum pre-conditioned arrays. Homopoly-
mers with highest attachment (>0.4 relative to highest number of
cells/mm2) or cell size (>500 mm2) and an inter-replication vari-
ability co-efﬁcient of <60% were selected for the second generation
array. In addition, we selected 2 polymers that did not support cell
Fig. 1. Polymer microarray fabrication, hESC-CM seeding and analysis. (A) hESC cardiomyocytes are derived via embryoid bodies and disaggregated to seed microarrays. (B) Contact
printing was used to fabricate polymer microarrays on a glass slide coated with pHEMA to prevent background cell adhesion. (C) DAPI and cardiac sarcomeric a actinin images of
cardiomyocyte adhesion were analyzed by CellProﬁler® to generate cell density and morphological data (D) Cell adhesion (bars) and size (circles) on 24 selected polymers from an
initial 116 polymer screen in serum-free (SF, blue) and FBS pre-treated conditions (red). (n ¼ 3, ±SEM). (E) Monomer identities. (F) These were mixed pair wise in 70/30 (v/v)
mixtures to generate a 576 co-polymer microarray; heat map of cell adhesion is shown (n ¼ 3). Scale bars ¼ 100 mm. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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that supported adhesion on serum treated arrays but not in serum-
free conditions (monomers 1, 9, 13 and 18) (Fig. 1D). These 24
monomers were mixed pair-wise in 70/30 (% v/v) ratios to produce
a combinatorial array of 576 co-polymers and as for the ﬁrst gen-
eration array, we seeded with EB derived hESC-CMs and culturedfor 7 days prior to assessment using a-actinin staining (Fig. 1C). A
total of 20 of these unique 576 co-polymers supported high levels
of relative attachment (>0.4) (Fig. 1F) and average cell size
(>500 mm2) (Fig. S4). Poly (dimethylamino propyl acrylamide)
(monomer 24) was identiﬁed to have a dominant negative inﬂuence
on cell adhesion in every co-polymer mixture where it was the
A.K. Patel et al. / Biomaterials 61 (2015) 257e265 261major monomer at 70% v/v (Fig. 1F). However, other trends were
less obvious and required further systematic analysis.3.3. Surface analysis and statistical modeling identiﬁes chemical
moieties that inﬂuence cardiomyocyte adhesion
Since a subset of polymers could improve hESC-CM adhesion
and morphology, we aimed to determine which substrate proper-
ties were important in controlling cell behavior. Surface elemental
composition data determined by X-ray photoelectron spectroscopy
(XPS) and hydrophilicity measured by water contact angle (WCA),
did not correlate to differences observed in cardiomyocyte adhe-
sion and spreading (Fig. S6). In agreement with previous studies
[28,31],WCAmeasurements revealed that the highest cell adhesion
and spreading (cell size) was seen on polymers that had a WCA
between 6080, although lower cell adhesion and size was also
observed within this range indicating WCA alone could not deter-
mine cell response to the substrate. To probe surface chemistry in
greater detail, time-of-ﬂight secondary-ion mass spectrometry
(ToF-SIMS) was carried out to identify the important chemical
moieties in the uppermost 2 nm of the surface. Surface character-
ization is essential to conﬁrm the identity of surface chemistry
available for cellular interaction, which may be different to the bulk
chemistry [12]. To establish if there was any correlation between
polymer surface chemistry and cell behavior, multivariate linear
regressionwas employed as described in detail elsewhere [32e34].
The analysis found that there was a correlation between surface
chemistry and cardiomyocyte adhesion (R2 ¼ 0.64) and cell size
(R2 ¼ 0.78) (Fig. 2). Over 1300 positive and negative secondary ions
detected from each substrate on the microarray by ToF-SIMS were
assigned a regression vector (RV) to describe their effect on cellFig. 2. Partial least squares multivariate linear regression. (A) The table lists ions identiﬁed
regression vector (RV) describes the ion having an additive effect on density or cell area a
example while ion C2H6Nþ has been modeled to improve cell density, it has a negative impac
data set, black). The model was validated using data that had not been introduced during tr
the R2 value is 0.78 (training set) and 0.72 (test set). (D) Surface ion intensity found by ToF-SI
the highest relative intensities. (For interpretation of the references to color in this ﬁgure lbehavior. Large positive vectors indicated a positive effect of these
secondary ions on cell density or area, whereas secondary ions
assigned a negative value are associated with a detrimental effect
on the cell response. The secondary ion C2H6Nþ was assigned
vectors of 0.5 for density and 0.05 for area (Fig. 2). This ion was
most intense in the polymer 17 and mirrors experimental data
where adhesion to the polymerwas relatively high but cell areawas
amongst the lowest (Fig. 1C). The cyclic ions C5H5Oþ and C10H17þ ,
most intense from polymers of 14 and 15 respectively (Fig. 2D),
were identiﬁed as having positive effects on both cell adhesion/area
with RV's of 0.8/1.00 and 0.5/0.01 respectively (Fig. 2A). The sec-
ondary ion C2H3O2, which was most intense from pHEMA, was
assigned negative RVs for both cell density and area (0.8/0.16).
This indicates pHEMA from the underlying slidewas contaminating
the surface of some polymer islands. Detection of this contaminant
highlights the importance of characterizing surface chemistry
rather than assuming its identity from the monomer composition.
To validate the robustness of the model, 20% of substrate data
that were not included when generating the model were then used
as a test data set [25]. The model was able to predict cell adhesion
(R2 ¼ 0.53) and area (R2 ¼ 0.72) based only on the surface chemical
characterization of these substrates acquired using ToF-SIMS
(Fig. 2B, C). The chemical moieties, C2H6Nþ, C5H5Oþ and C10H17þ ,
which dominate the positive cell response on the array, may serve
useful for tailoring substrate chemistry to manipulate car-
diomyocyte adhesion and morphology and to gain greater under-
standing of cellesubstrate interactions. It is also important to
appreciate the subtle additive effects of ions that are assigned
smaller RVs. For example, polymer 18 does not contain high in-
tensities of the ions identiﬁed in Fig. 2A but when co-polymerized
with monomer 3 contributes to an overall improvement ofby the model to be important in inﬂuencing cell density or cell size (area). A positive
nd a negative RV describes the ion as being detrimental on cell adhesion or area. For
t on cell area. (B) The model for predicting cell density has an R2 value of 0.64 (training
aining of the model (test set, blue). The R2 value for the test set is 0.53. (C) For cell area
MS of moieties identiﬁed by PLS has been plotted for selected polymers where they had
egend, the reader is referred to the web version of this article.)
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polymer alone (Fig. 3A).
3.4. Electrophysiological function is maintained in hESC-CMs
cultured on hit co-polymers in serum-free conditions
We examined hESC-CM structure and function in detail on 3 co-
polymers; furfuryl methacrylate (70% v/v) with tert-butylamino-
ethyl methacrylate at 30% v/v (14/17), isobornyl methacrylate
mixed with the same minor monomer (15/17) and hexanediol
ethoxylate diacrylate polymerized with ethoxyethyl methacrylate
(3/18). These were selected because they were amongst the top
performing co-polymers where the performance of the co-polymer
exceeded that of the constitutive homopolymers (Fig. 3A) and
contained chemical moieties that were identiﬁed by multivariate
analysis to be of importance (Fig. 2D). The co-polymers of 14/17, 15/
17 and 3/18 supported high cardiomyocyte densities (0.4, 0.5 and
0.7 respectively) as well as larger cell size (977 mm2, 1033 mm2 and
899 mm2 respectively) (Fig. 3A). There is growing interest within the
pharmaceutical industry to use hESC-CMs in drug safety evaluation
to detect fatal drug-induced ventricular arrhythmias, such as
Torsade de Pointes [35]. Since electrophysiological function is vital
for this use we tested whether synthetic polymers could support
beating cardiomyocytes. We scaled up co-polymers by piezo-
printing a 600 mm wide line of polymer across the center of
35 mm dishes (Fig. 3B) that had been prepared by oxygen plasmaFig. 3. Structural and electrophysiological characterization of hESC-CMs after 15 days cultur
selected co-polymers compared to their constituent homopolymers (n ¼ 4, ±SEM). (B) The
shown with the corresponding immunostained image, a actinin (red) and DAPI (blue). (C) V
patch clamp electrophysiology. Characterization of ventricular AP parameters reveals that up
to control. No statistical difference was observed in action potential duration at 90% repolariz
n ¼ 5, 14/17 n ¼ 4, 03/18 n ¼ 3, control n ¼ 3 cells, þSEM. (D) Structural analysis of the cardio
was measured using Image J line proﬁle tool (yellow intensity graph). Structural maturity wa
synthetic polymers compared to control (3 measurements per cell, 4 cells measured per im
color in this ﬁgure legend, the reader is referred to the web version of this article.)etching followed by pHEMA coating. hESC-CMs were cultured on
these substrates for 15 days and then subjected to whole cell patch
clamp electrophysiology. Ventricular sub-types were analyzed to
ﬁnd that action potential duration at 90% repolarization (APD90),
amplitude and maximal diastolic potential were comparable to
hESC-CMs on gelatin controls, the upstroke velocity increased six-
fold on co-polymer 15/17 (21.8 V/s, P< 0.05) and almost two-fold on
14/17 (5.8 V/s, P < 0.05) compared to hESC-CMs cultured on gelatin
control (3.4 V/s) (Fig. 3C). Despite this modest improvement in
velocity compared to values reported for primary human fetal
cardiomyocytes (~8 V/s) [36], overall electrophysiological maturity
remains low compared to adult human cardiomyocytes (~250 V/s)
[36,37] similar to values reported for other stem cell derived car-
diomyocytes, which also exhibit immature action potential proﬁles
[38,39]. Adding maturity-promoting factors to the minimally
complex medium we selected for this study could be a strategy to
systematically test factors without confounding cues arising from
chemically undeﬁned substrates.
3.5. Synthetic substrates support cardiomyocytes with improved
myoﬁbril organization and evaluation of drug toxicity caused by
myoﬁbril disruption
Cardiomyocytes were examined for a-actinin staining patterns
as a rapid gauge of structural integrity. The distance between the Z
bands correspond to sarcomere length, the basic motor units thate on co-polymers and control 0.1% gelatin (A) Cardiomyocyte adhesion and cell size on
three co-polymers were scaled up in 35 mm dishes, a brightﬁeld image of hPSC-CM is
entricular, atrial and nodal-like action potentials (AP) were obtained using whole cell
stroke velocity is faster in cardiomyocytes cultured on polymers 15/17 and 14/17 relative
ation (APD90), amplitude and maximal diastolic potential (MDP). T-Test, p < 0.05, 15/17
myocyte; the white arrow highlights one sarcomere unit. The length of each sarcomere
s improved as indicated by longer sarcomere length in cardiomyocytes cultured on the
age, n ¼ 3, þSD, T test, *p < 0.05, **p < 0.005). (For interpretation of the references to
A.K. Patel et al. / Biomaterials 61 (2015) 257e265 263make up the myoﬁbril. Longer sarcomeres of up to 2.2 mm indicate
structural maturity of themyocyte [40] and correlates to contractile
functionality as determined by the Frank Starling mechanism [41].
Relative to control hESC-CMs on gelatin (sarcomere length
1.50 mm), those on co-polymers 14/17, 15/17 and 3/18 had signiﬁ-
cantly longer lengths of 1.97 mm (p < 0.005), 1.80 mm (p < 0.05) and
1.70 mm (p < 0.05) respectively (Fig. 3D). To assess if hESC-CMs
derived from an alternative method could also maintain struc-
tural integrity on the synthetic polymer, we used a monolayer
protocol to derive hESC-CMs and seeded them on polymer 15/17.
hESC-CMs on control displayed high variability in sarcomere length
(1.63 mm ± 0.29) compared to hESC-CMs on polymer 15/17 where
myoﬁbrils had a more consistent length of (1.97 mm ± 0.095)
(Fig. 4A). We reasoned that the utility of improved sarcomeric or-
ganization would be demonstrated in detecting toxicity of drugs
that affect cell structure. The anti-cancer drug doxorubicin can
cause cardiotoxicity at therapeutic concentrations of 0.01e0.04 mM
[42,43], one indication of this toxicity is myoﬁbril disruptions [44].
However, in vitro assays, using rat, human and mouse cells can only
detect structural changes at 0.5 mM and higher [45e47]. Disruption
of sarcomeric organization was deﬁned as a sarcomere length
below 1.4 mm indicating ‘pre-myoﬁbrils’ [23] or punctate a-actinin
staining where no myoﬁbril banding could be observed. In accor-
dance with the literature, our study also found that disruption of
sarcomeric structure of hESC-CMs cultured on gelatin could be
observed at 0.5 mM (P < 0.005) but not at 0.05 mM (Fig. 4B, C). The
higher reproducibility of myoﬁbril alignment in hESC-CMs on
polymer 15/17 meant that perturbation could be detected at the
lower and more relevant therapeutic dose of 0.05 mM (P < 0.005).
This represents up to a 10-fold improvement in detection sensi-
tivity to doxorubicin of hESC-CMs cultured on synthetic polymers
relative to those on gelatin or other in vitro systems available.Fig. 4. Structural Characterization of monolayer derived hESC-CMs after 15 days culture on c
by doxorubicin. (A) Structural organization of hESC-CMs was improved as indicated by long
control (3 measurements per cell, 4 cells measured per image, n ¼ 3, þSD. (B) Cardiomyocyte
in their myoﬁbril organization signiﬁcant at 0.05 mM compared to control cardiomyocytes o
250 cells analyzed per condition). (C) a actinin (red) and DAPI (blue) immunostains reveal th
of 0.05 mM doxorubicin ‘pre-myoﬁbrils’ with sarcomere lengths of less than 1.4 mm can b
myoﬁbril alignment is seen. (For interpretation of the references to color in this ﬁgure lege4. Discussion
The comparison of various substrates for supporting car-
diomyocytes has previously been investigated by banding surfaces
into broad groups of positively/negatively charged, acid/base or
hydrophilic/hydrophobic chemistries [48,49]. In this study, using a
combination of unbiased parallel screening and systematic statis-
tical modeling, an unprecedented library of polymers were sur-
veyed to identify speciﬁc chemical groups C2H6Nþ (amine), C5H5Oþ
(furan ring) and C10H17þ (isobornyl ring) that improve the adhesion
density of human cardiomyocytes in serum-free conditions.
The amine functionality in poly(tert-butylamino ethyl methac-
rylate), is positively charged at physiological pH [50] and ionic
interaction with negatively charged cell membrane proteins are
thought to facilitate cell adhesion [51]. The mechanism of how the
cyclic moieties help to maintain cardiomyocyte function in vitro is
yet to be elucidated but provides the basis for tailored design of
culture substrates that could not have been predicted from existing
knowledge of cellematerial interactions.
Substrates reported in the literature to support cardiomyocyte
adhesion do so under conditions that include FBS in the culture
medium, which aids adhesion by coating the substrate in proteins
such as vitronectin [52]. Comparison of various substrates can be
distorted by variations in the undeﬁned components within FBS. In
this study, the removal of serum from culture meant that con-
founding components were eliminated. Although this reduced the
proportion of homopolymers that were able to support cell adhe-
sion, combinatorial mixtures of polymers that were found to sup-
port either greater adhesion or larger cell area, increased the
diversity of substrates able to support functional cardiomyocytes in
serum-free conditions.
At 7 day (Fig. S5) and 15 day time points, a co-polymer ofo-polymer 15/17 compared to control 0.1% gelatin and detection of myoﬁbril disruption
er sarcomere length on polymer 15/17 with lower deviation compared to 0.1% gelatin
s on the synthetic polymer 15/17 have a more organized sarcomeres making disruption
n gelatin where disruption of myoﬁbrils is not statistically detected at 0.05 mM (n ¼ 3,
at untreated cardiomyocytes on polymer 15/17 contain organized myoﬁbrils. At a dose
e observed and at a dose of 0.5 mM, more obvious punctate staining with absence of
nd, the reader is referred to the web version of this article.)
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was identiﬁed to support cardiomyocytes with sarcomere lengths
that were signiﬁcantly longer with lower deviation than car-
diomyocytes on control gelatin. The improvement in myoﬁbril or-
ganization was demonstrated in hESC-CMs derived from embryoid
body and monolayer differentiation methods. The utility of greater
sarcomeric organizationwas exempliﬁed by increased sensitivity of
toxicity detection to the anti-cancer drug, doxorubicin, demon-
strating the need for reproducible culture of cardiomyocytes in
order for them to be used reliably for pharmacological assays.
Importantly, our studies used human origin cardiomyocytes so that
the ﬁndings are directly translatable and not subject to reported
differences such as rat cardiomyocytes being able to adhere to a
greater proportion of substrates compared to the more fastidious
human cardiomyocyte [53]. Challenges remain in optimizing the
overall culture system to obtain electrophysiological proﬁles com-
parable to those reported for adult human cardiomyocytes.
Exploitation of polymer structureefunction relationships identiﬁed
in this study to maintain cardiomyocytes on chemically deﬁned
substrates, addition of soluble cues that promote maturation and
the move into 3D systems will be explored to overcome this
challenge.
5. Conclusions
The materials investigated in this study provide a deﬁned,
reproducible and economically viable alternative to biological
matrices and their discovery could not have been predicted from
existing knowledge of cellematerial interactions.
The identiﬁcation of chemically characterized cardio-supportive
moieties provides the basis for the rational design of substrates to
build into controlled culture systems where further improvement
of cell maturation using soluble cues or 3D design (e.g. culture
medium components and the physical form of the substrate) can be
systematically investigated without the contribution of uncharac-
terized cues arising from biological matrices.
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